# ODSSEY-SCD\_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY

Study · id `cardio:ct-nct07545512` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07545512](<https://clinicaltrials.gov/study/NCT07545512>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07545512

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT07545512. Non-randomized; no masking; primary purpose other. Start 2026-09-24 (actual); primary completion 2033-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT07545512, source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)
- Started: 2026-09-24 (actual) (ClinicalTrials.gov record NCT07545512, source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2033-07-01 (anticipated) (ClinicalTrials.gov record NCT07545512, source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)
- Completion: 2033-07-01 (anticipated) (ClinicalTrials.gov record NCT07545512, source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)
- Countries: France (ClinicalTrials.gov record NCT07545512, source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07545512-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: ODSSEY-SCD\_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
- Acronym: ODISSEY
- Condition: Myocardial Infarction (MI)
- Condition: Sudden Cardiac Death Due to Cardiac Arrhythmia
- Intervention (Device): This study involved an auxillary CE-marked medical device (implantable holter for cardiac rhythm monitoring)
- Lead sponsor: University Hospital, Clermont-Ferrand
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: University Hospital, Clermont-Ferrand (`cardio:org-university-hospital-clermont-ferrand`)

## Provenance

Content hash: 64b57c12770c27792bf5f6607b64ec57315f403f86696d8064ad55cd747c086e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
